Investing.com - Avanos Medical (NYSE: AVNS) reported second quarter EPS of $0.34, $0.05 better than the analyst estimate of $0.29. Revenue for the quarter came in at $171.7M versus the consensus estimate of $170.67M.
Guidance
Avanos Medical sees FY 2024 EPS of $1.30-$1.45 versus the analyst consensus of $1.38.
Avanos Medical sees FY 2024 revenue of $685.00M-$705.00M versus the analyst consensus of $695.40M.
Avanos Medical's stock price closed at $22.96. It is up 16.67% in the last 3 months and down -4.49% in the last 12 months.
Avanos Medical saw 1 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Avanos Medical's stock price’s past reactions to earnings here.
According to InvestingPro, Avanos Medical's Financial Health score is "great performance".
Check out Avanos Medical's recent earnings performance, and Avanos Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar